PolymarketVerifica disponibilitàSenza KYC2% di commissioneDati di risoluzione verificatiDiscretamente calibratoProbabilità implicita attuale
Sì 87.1%+1.0pt
Qualita del mercato
74 / 100
Qualità mediaVolume 24h
15,4K €
Liquidità
4,4K €
Liquidità mediaBid / Ask
87.0% / 88.0%
Spread
1.0 pt
Spread strettoComments
0
Dati di mercato
Aggiornato 11 minuti fa
19 ago 26, 18:4730 giu 27, 23:59
Trend
Regole
This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- Intismeran autogene refers to the individualized neoantigen therapy developed by Moderna and Merck and evaluated in the Phase 3 INTerpath-001 trial (NCT05933577), also known as mRNA-4157 and V940, together with any brand, trade, or nonproprietary name later assigned to that product, as well as any renamed or modified version that the relevant company or the FDA identify as the same product or a direct continuation of the V940/mRNA-4157 program.
- A qualifying application must seek FDA licensure of intismeran autogene through a Biologics License Application (BLA).
- An original BLA or a resubmission of such a BLA following FDA action will qualify.
- The application may cover any indication.
Mercati aperti
Health & Medicine
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+0.1pt4%
- Volume totale
- 1,6 Mln €
- Volume 24h
- 15K €
POLYMARKETHantavirus pandemic in 2026?
- No+0.1pt97%
- Yes-0.1pt3%
- Volume totale
- 15,3 Mln €
- Volume 24h
- 8,9K €
KALSHIMeasles cases in 2026?
- Above 3000-1.0pt96%
- Above 4000-1.0pt81%
- Above 6000+5.0pt29%
+2 altri esiti
- Volume totale
- 782,3K €
POLYMARKETHeidi Overton confirmed as FDA Commissioner by which date?
- December 3172%
- October 3133%
- November 3033%
+1 altri esiti
- Volume totale
- 6,5K €
KALSHIWhen will Heidi Overton be confirmed as Commissioner of the FDA?
- Before Aug 1, 202774%
- Before Apr 1, 202767%
- Before Jan 1, 202767%
+2 altri esiti
- Volume totale
- 4,5K €
- Volume 24h
- 3,7K €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+2.0pt68%
- June 30,-7.5pt24%
- Volume totale
- 38,6K €
- Volume 24h
- 3,4K €
- Will 3 mg THC beverages qualify as hemp under federal law?
- New pandemic in 2026?
- Measles cases in U.S. by August 31?
- How many human screwworm cases will be reported in the United States in 2026?
- Which countries will report an Ebola disease case before October?
- Hantavirus vaccine in 2026?
- Ebola pandemic in 2026?
- FDA decision: Brepocitinib by Priovant Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
Domande frequenti
- Quali sono le probabilità attuali per Skin cancer vaccine BLA submitted by June 30, 2027??
- Polymarket quota Yes al 87% al 21 agosto 2026.
- Quando si risolve Skin cancer vaccine BLA submitted by June 30, 2027??
- Skin cancer vaccine BLA submitted by June 30, 2027? dovrebbe risolversi il 30 giugno 2027.
- Come viene liquidato Skin cancer vaccine BLA submitted by June 30, 2027??
- Polymarket liquida questo mercato come segue: This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET.